LXEO Lexeo Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$3,53
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,98mínimo 52 semanas
$10,99máximo 52 semanas
Capitalización Bursátil (MRQ)
$278M
P/E
-1.9
BPA
$-1.86
tus insignias
Rango 52S
$3–$11
Calificación del Analista
STRONG BUY
Precio Objetivo
$20
P/E
-1.9
ROE
-51.9%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
LXEO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.53
Capitalización Bursátil (MRQ)
$278M
P/E
-1.9
BPA
$-1.86
ROE
-51.9%
Rango 52S
$3–$11
LXEO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos·2022-12-31 → 2022-12-31
BPA$-1.862022-12-31 → 2025-12-31
Flujo de caja libre$-99M2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | LXEO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.9promedio 5A ≈-2.9 | ≈-2.9 | · | · | |
| P/C (MRQ) | 1.2promedio 5A ≈2.7 | ≈2.7 | 3.0 | Infravalorado | |
| Precio / FCF (TTM) | -3.1promedio 5A ≈-5.3 | ≈-5.3 | · | · | |
| Precio / Flujo de Caja (TTM) | -3.1promedio 5A ≈-5.3 | ≈-5.3 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.0promedio 5A ≈2.7 | ≈2.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | LXEO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -48.1%promedio 5A ≈-57.6% | ≈-57.6% | -31.8% | Débil | |
| ROE | -51.9%promedio 5A ≈46.9% | ≈46.9% | -41.9% | Débil | |
| ROIC | -44.3% | · | -1.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | LXEO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 13.9promedio 5A ≈8.0 | ≈8.0 | 4.7 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 3.7promedio 5A ≈5.4 | ≈5.4 | 4.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
9.6%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 19, 2026 | $-0.30 | $-0.29 | -3.2% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.25 | $-0.32 | 21.8% |
| 31 de diciembre de 2025 | $-0.27 | $-0.32 | 15.8% | |
| 30 de septiembre de 2025 | $-0.33 | $-0.53 | 37.8% | |
| 30 de junio de 2025 | $-0.60 | $-0.69 | 13.5% | |
| 31 de marzo de 2025 | $-0.99 | $-0.80 | -23.9% | |
| 31 de diciembre de 2024 | $-0.78 | $-0.82 | 5.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | · | · | · | $654.0K | |
| R&D Expense | $64M | $74M | $53M | $49M | |
| SG&A Expense | $45M | $32M | $15M | $12M | |
| Operating Expenses | $109M | $106M | $69M | $61M | |
| Operating Income | $-109M | $-106M | $-69M | $-61M | |
| Interest Expense | · | · | $205.0K | $91.0K | |
| Interest Income | $6M | $8M | $3M | $1M | |
| Other Non-op | $-18.0K | $-9.0K | $-13.0K | $-2.0K | |
| Pretax Income | $-100M | $-98M | $-66M | $-59M | |
| Income Tax | $0 | $0 | · | · | |
| Net Income | $-100M | $-98M | $-66M | $-59M | |
| EPS (Basic) | $-1.86 | $-3.09 | $-12.40 | $-36.36 | |
| EPS (Diluted) | $-1.86 | $-3.09 | $-12.40 | $-36.36 | |
| Shares (Basic) | 53,645,323 | 31,787,491 | 5,354,368 | 1,630,348 | |
| Shares (Diluted) | 53,645,323 | 31,787,491 | 5,354,368 | 1,630,348 | |
| EBITDA | $-109M | $-106M | $-69M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $35M | $121M | $77M | |
| Short-term Investments | · | $87M | · | · | |
| Prepaid Expense | $7M | $5M | $3M | $2M | |
| Other Current Assets | · | · | $3.0K | $371.0K | |
| Current Assets | $188M | $126M | $124M | $80M | |
| PP&E (Net) | $1M | $1M | $1M | $998.0K | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | $741.0K | $474.0K | $381.0K | $133.0K | |
| Total Assets | $269M | $147M | $140M | $97M | |
| Accounts Payable | $5M | $6M | $4M | $3M | |
| Current Liabilities | $17M | $23M | $17M | $14M | |
| Capital Leases | $5M | $6M | $8M | $9M | |
| Total Liabilities | $22M | $30M | $26M | $25M | |
| Common Stock | $7.0K | $3.0K | $3.0K | $0 | |
| Retained Earnings | $-380M | $-280M | $-182M | $-115M | |
| Treasury Stock | $17.0K | $17.0K | · | · | |
| AOCI | $188.0K | $-103.0K | · | · | |
| Stockholders' Equity | $247M | $117M | $114M | $-113M | |
| Liabilities + Equity | $269M | $147M | $140M | $97M | |
| Shares Outstanding | 73,001,350 | 33,071,261 | 26,646,378 | 1,607,185 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $268.0K | $304.0K | $271.0K | $120.0K | |
| Stock-based Comp | $12M | $12M | $3M | $2M | |
| Operating Cash Flow | $-99M | $-81M | $-59M | $-55M | |
| CapEx | $397.0K | $481.0K | $115.0K | $672.0K | |
| Investing Cash Flow | $-90M | $-94M | $-165.0K | $-901.0K | |
| Stock Issued | $270.0K | · | · | · | |
| Net Stock Activity | $270.0K | · | · | · | |
| Financing Cash Flow | $217M | $89M | $104M | $189.0K | |
| Net Change in Cash | $28M | $-86M | $44M | $-55M | |
| Taxes Paid | $551.0K | $133.0K | · | · | |
| Free Cash Flow | $-99M | $-82M | $-60M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -48.1% | -68.6% | -56.1% | · | |
| ROE | -51.9% | -76.8% | 269.5% | · | |
| ROIC | -44.3% | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 11.2 | 5.5 | 7.2 | · | |
| Quick Ratio | 3.7 | 5.3 | 7.0 | · | |
| Interest Coverage | · | · | -334.2 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $3.38 | $3.53 | $4.26 | · | |
| Cash Flow / Share | $-1.84 | $-2.55 | $-11.11 | · | |
| Cash / Share | $0.86 | $1.06 | $4.56 | · | |
| EPS (TTM) | $-1.86 | $-3.09 | $-12.40 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-100M | $-98M | $-66M | · | |
| Market Cap | $725M | $218M | $358M | · | |
| P/E | -5.3 | -2.1 | -1.1 | · | |
| P/B | 2.9 | 1.9 | 3.1 | · | |
| P / Tangible Book | 2.9 | 1.9 | 3.1 | · | |
| P / Cash Flow | -7.4 | -2.7 | -6.0 | · | |
| P / FCF | -7.3 | -2.7 | -6.0 | · | |
| Earnings Yield | -18.7% | -47.0% | -92.4% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $531.0K | |
| R&D Expense | $19M | $16M | $16M | $16M | $15M | $17M | $18M | $23M | $17M | $16M | $8M | $17M | $11M | $16M | $11M | $15M | |
| SG&A Expense | $9M | $7M | $7M | $6M | $16M | $17M | $9M | $8M | $7M | $8M | $7M | $3M | $3M | $3M | $4M | $3M | |
| Operating Expenses | $28M | $22M | $23M | $22M | $31M | $34M | $27M | $32M | $24M | $23M | $15M | $20M | $14M | $19M | $15M | $18M | |
| Operating Income | $-28M | $-22M | $-23M | $-22M | $-31M | $-34M | $-27M | $-32M | $-24M | $-23M | $-15M | $-20M | $-14M | $-19M | $-15M | $-17M | |
| Interest Expense | · | · | · | · | · | · | · | · | $35.0K | $37.0K | · | $52.0K | $53.0K | $50.0K | $54.0K | $29.0K | |
| Interest Income | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $488.0K | $590.0K | $687.0K | $676.0K | $456.0K | |
| Other Non-op | $-6.0K | $-1.0K | $9.0K | $-9.0K | $-14.0K | $-4.0K | $0 | $-3.0K | $-1.0K | $-5.0K | $-7.0K | $1.0K | $-3.0K | $-4.0K | · | · | |
| Pretax Income | $-26M | $-20M | $-21M | $-20M | $-26M | $-33M | $-26M | $-29M | $-21M | $-22M | $-14M | $-20M | $-13M | $-19M | $-15M | $-17M | |
| Net Income | $-26M | $-20M | $-21M | $-20M | $-26M | $-33M | $-26M | $-29M | $-21M | $-22M | $-14M | $-20M | $-13M | $-19M | $-15M | $-17M | |
| EPS (Basic) | $-0.30 | $-0.25 | $0.06 | $-0.33 | $-0.60 | $-0.99 | $-0.79 | $-0.89 | $-0.64 | $-0.77 | $19.84 | $-12.36 | $-8.30 | $-11.58 | $-8.86 | $-10.38 | |
| EPS (Diluted) | $-0.30 | $-0.25 | $0.06 | $-0.33 | $-0.60 | $-0.99 | $-0.79 | $-0.89 | $-0.64 | $-0.77 | $19.84 | $-12.36 | $-8.30 | $-11.58 | $-8.86 | $-10.38 | |
| Shares (Basic) | 85,626,751 | 81,183,812 | · | 60,980,867 | 43,573,628 | 33,113,991 | · | 33,063,153 | 33,001,946 | 27,979,838 | · | 1,626,734 | 1,619,547 | 1,610,793 | · | 1,643,122 | |
| Shares (Diluted) | 85,626,751 | 81,183,812 | · | 60,980,867 | 43,573,628 | 33,113,991 | · | 33,063,153 | 33,001,946 | 27,979,838 | · | 1,626,734 | 1,619,547 | 1,610,793 | · | 1,643,122 | |
| EBITDA | $-28M | $-22M | · | $-22M | $-31M | · | · | $-32M | $-24M | $-23M | · | $-20M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $72M | $63M | $41M | $35M | $29M | $35M | $157M | $175M | $195M | $121M | $35M | · | · | $77M | · | |
| Short-term Investments | · | · | · | · | · | $71M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $8M | $7M | $5M | $7M | $5M | $5M | $2M | $2M | $3M | $3M | $1M | · | · | $2M | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | $371.0K | · | |
| Current Assets | $218M | $201M | $188M | $128M | $140M | $105M | $126M | $159M | $177M | $198M | $124M | $39M | · | · | $80M | · | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $980.0K | · | · | $998.0K | · | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | · | · | $1M | · | |
| Accum. Depreciation | $887.0K | $814.0K | $741.0K | $668.0K | $596.0K | $534.0K | $474.0K | $610.0K | $527.0K | $450.0K | $381.0K | $316.0K | · | · | $133.0K | · | |
| Total Assets | $255M | $250M | $269M | $144M | $176M | $126M | $147M | $174M | $192M | $213M | $140M | $55M | · | · | $97M | · | |
| Accounts Payable | $4M | $3M | $5M | $5M | $20M | $12M | $6M | $8M | $6M | $4M | $4M | $3M | · | · | $3M | · | |
| Current Liabilities | $16M | $14M | $17M | $17M | $32M | $31M | $23M | $27M | $19M | $22M | $17M | $23M | · | · | $14M | · | |
| Capital Leases | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | · | · | $9M | · | |
| Total Liabilities | $20M | $19M | $22M | $23M | $38M | $38M | $30M | $35M | $27M | $30M | $26M | $32M | · | · | $25M | · | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $0 | · | · | $0 | · | |
| Retained Earnings | $-426M | $-400M | $-380M | $-359M | $-339M | $-313M | $-280M | $-254M | $-225M | $-204M | $-182M | $-168M | · | · | $-115M | · | |
| Treasury Stock | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $13.0K | $13.0K | · | · | · | · | · | · | · | |
| AOCI | $-298.0K | $-142.0K | $188.0K | $89.0K | $-13.0K | $-54.0K | $-103.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $235M | $231M | $247M | $121M | $138M | $88M | $117M | $139M | $165M | $183M | $114M | $-163M | · | · | $-113M | · | |
| Liabilities + Equity | $255M | $250M | $269M | $144M | $176M | $126M | $147M | $174M | $192M | $213M | $140M | $55M | · | · | $97M | · | |
| Shares Outstanding | 78,622,604 | 74,086,737 | 73,001,350 | 54,934,275 | 53,998,492 | 33,191,865 | 33,071,261 | 33,058,447 | 33,039,911 | 32,928,141 | 26,646,378 | 1,633,206 | · | · | 1,607,185 | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $74.0K | $73.0K | $73.0K | $73.0K | $62.0K | $60.0K | $75.0K | $83.0K | $77.0K | $69.0K | $77.0K | $78.0K | $59.0K | $57.0K | $58.0K | · | |
| Stock-based Comp | $6M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | $2M | $804.0K | $875.0K | $969.0K | $397.0K | $521.0K | $431.0K | |
| Operating Cash Flow | $-18M | $-21M | $-20M | $-30M | $-27M | $-22M | $-28M | $-18M | $-20M | $-15M | $-14M | $-14M | $-13M | $-18M | $-17M | · | |
| CapEx | $7.0K | $35.0K | $0 | $289.0K | · | · | $0 | $83.0K | $213.0K | $185.0K | $73.0K | $3.0K | · | · | $25.0K | · | |
| Investing Cash Flow | $14M | $27M | $-102M | $35M | $-39M | $16M | $-94M | $-83.0K | $-218.0K | $-193.0K | $-73.0K | $-53.0K | · | · | $-107.0K | · | |
| Stock Issued | $25M | $143.0K | $-1.0K | $101.0K | $0 | $170.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $143.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $144M | $52.0K | $73M | $11.0K | $-97.0K | $-72.0K | $291.0K | $89M | $100M | $4M | $-94.0K | $-98.0K | $-81.0K | · | |
| Net Change in Cash | $21M | $9M | $22M | $6M | $7M | $-6M | $-122M | $-18M | $-20M | $74M | $86M | $-10M | $-13M | $-18M | $-17M | · | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | $-15M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.0% | -10.7% | · | -12.8% | -14.2% | · | · | -25.8% | -22.1% | -20.3% | · | -73.5% | · | · | · | · | |
| ROE | -13.9% | -12.6% | · | -15.6% | -17.2% | · | · | 251.2% | -25.8% | -23.7% | · | 24.7% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.9 | 14.2 | · | 7.4 | 4.4 | · | · | 5.9 | 9.4 | 9.2 | · | 1.7 | · | · | · | · | |
| Quick Ratio | 5.9 | 5.1 | · | 2.4 | 1.1 | · | · | 5.9 | 9.3 | 9.0 | · | 1.5 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -672.9 | -629.5 | · | -389.9 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.99 | $3.12 | · | $2.20 | $2.56 | · | · | $4.21 | $4.99 | $5.56 | · | $-99.69 | · | · | · | · | |
| Cash Flow / Share | · | $-0.26 | · | · | · | · | · | · | · | $-0.53 | · | · | · | · | · | · | |
| Cash / Share | $1.18 | $0.97 | · | $0.75 | $0.66 | · | · | $4.75 | $5.30 | $5.92 | · | $21.71 | · | · | · | · | |
| EPS (TTM) | $-0.82 | $-1.12 | · | $-2.71 | $-3.27 | $-3.29 | · | $17.54 | $6.07 | $-1.59 | · | $-41.10 | $-39.12 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-87M | $-88M | · | $-105M | $-114M | $-105M | · | $-87M | $-77M | $-69M | · | $-67M | $-64M | $-65M | · | · | |
| Market Cap | $366M | $425M | · | $365M | $217M | · | · | $299M | $530M | $516M | · | · | · | · | · | · | |
| P/E | -5.7 | -5.1 | · | -2.5 | -1.2 | -1.1 | · | 0.5 | 2.6 | -9.9 | · | · | · | · | · | · | |
| P/B | 1.6 | 1.8 | · | 3.0 | 1.6 | · | · | 2.1 | 3.2 | 2.8 | · | · | · | · | · | · | |
| P / Tangible Book | 1.6 | 1.8 | · | 3.0 | 1.6 | 1.3 | · | 2.1 | 3.2 | 2.8 | · | · | · | · | · | · | |
| P / Cash Flow | · | -20.1 | · | · | · | · | · | · | · | -34.7 | · | · | · | · | · | · | |
| Earnings Yield | -17.6% | -19.5% | · | -40.8% | -81.3% | -94.8% | · | 194.0% | 37.8% | -10.1% | · | · | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Ingresos | · | · | · | $654.0K |
| Beneficio neto | $-100M | $-98M | $-66M | $-59M |
| EPS Diluido | $-1.86 | $-3.09 | $-12.40 | $-36.36 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Ratio corriente | 11.2 | 5.5 | 7.2 | · |
| Ratio Rápido | 3.7 | 5.3 | 7.0 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Flujo de caja libre | $-99M | $-82M | $-60M | · |
Propietarios institucionales (13F) 148 declarantes · $459.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
148
Valor en tenencia
$459.4M
Nuevas posiciones
28
Posiciones cerradas
19
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 28 (+5 vs trimestre anterior) | 19 (-5 vs trimestre anterior) | 58 (0 vs trimestre anterior) | 40 (+3 vs trimestre anterior) | +5.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $38 670 499 | 3 894 310 | 8,42% | Acciones |
| MONTANOVA CAPITAL, LLC | $29 718 451 | 6 384 200 | 6,47% | Acciones |
| JANUS HENDERSON GROUP PLC | $28 510 358 | 4 976 429 | 6,21% | Acciones |
| Affinity Asset Advisors, LLC | $27 034 429 | 5 807 611 | 5,88% | Acciones |
| BlackRock, Inc. | $26 717 165 | 5 739 455 | 5,82% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $23 275 000 | 5 000 000 | 5,07% | Acciones |
| Frazier Life Sciences Management, L.P. | $22 459 095 | 4 824 725 | 4,89% | Acciones |
| STATE STREET CORP | $20 271 394 | 4 354 757 | 4,41% | Acciones |
| Vestal Point Capital, LP | $20 109 600 | 4 320 000 | 4,38% | Acciones |
| Paradigm Biocapital Advisors LP | $19 436 403 | 4 175 382 | 4,23% | Acciones |
| ORBIMED ADVISORS LLC | $18 377 242 | 3 947 850 | 4,00% | Acciones |
| CITADEL ADVISORS LLC | $18 147 843 | 3 898 570 | 3,95% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $14 551 032 | 3 125 893 | 3,17% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $13 190 510 | 2 833 622 | 2,87% | Acciones |
| Woodline Partners LP | $11 639 976 | 2 500 532 | 2,53% | Acciones |
| Balyasny Asset Management L.P. | $11 231 314 | 2 412 742 | 2,44% | Acciones |
| GOLDMAN SACHS GROUP INC | $10 006 444 | 2 149 612 | 2,18% | Acciones |
| 683 Capital Management, LLC | $8 728 124 | 1 875 000 | 1,90% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $8 138 547 | 1 747 959 | 1,77% | Acciones |
| ADAR1 Capital Management, LLC | $7 289 497 | 1 565 950 | 1,59% | Acciones |
| Avoro Capital Advisors LLC | $6 932 175 | 1 489 189 | 1,51% | Acciones |
| Qube Research & Technologies Ltd | $6 406 313 | 1 376 222 | 1,39% | Acciones |
| Nantahala Capital Management, LLC | $6 051 500 | 1 300 000 | 1,32% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $5 992 745 | 1 287 185 | 1,30% | Acciones |
| Spruce Street Capital LP | $4 322 600 | 928 593 | 0,94% | Acciones |
| Blackstone Inc. | $4 217 109 | 904 959 | 0,92% | Acciones |
| NORTHERN TRUST CORP | $4 037 705 | 867 391 | 0,88% | Acciones |
| Aberdeen Group plc | $3 142 553 | 675 092 | 0,68% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 857 360 | 613 826 | 0,62% | Acciones |
| Ikarian Capital, LLC | $2 388 066 | 513 011 | 0,52% | Acciones |
| BANK OF AMERICA CORP /DE/ | $2 282 490 | 490 331 | 0,50% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 004 890 | 430 696 | 0,44% | Acciones |
| MORGAN STANLEY | $1 839 200 | 395 102 | 0,40% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 807 993 | 388 398 | 0,39% | Acciones |
| DAFNA Capital Management LLC | $1 755 210 | 377 059 | 0,38% | Acciones |
| UBS Group AG | $1 648 074 | 354 044 | 0,36% | Acciones |
| Trexquant Investment LP | $1 465 818 | 314 891 | 0,32% | Acciones |
| Squarepoint Ops LLC | $1 372 173 | 294 774 | 0,30% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $1 194 757 | 256 661 | 0,26% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 165 449 | 250 365 | 0,25% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $942 093 | 202 383 | 0,21% | Acciones |
| Nuveen, LLC | $932 941 | 200 417 | 0,20% | Acciones |
| Bank of New York Mellon Corp | $855 975 | 183 883 | 0,19% | Acciones |
| TWO SIGMA ADVISERS, LP | $807 309 | 81 300 | 0,18% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $803 495 | 172 609 | 0,17% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $749 744 | 161 062 | 0,16% | Acciones |
| Privium Fund Management B.V. | $722 300 | 155 000 | 0,16% | Acciones |
| XTX Topco Ltd | $677 563 | 145 556 | 0,15% | Acciones |
| FMR LLC | $657 035 | 141 146 | 0,14% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $634 835 | 136 377 | 0,14% | Acciones |
Informantes de la empresa 18 insiders · 9 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Richard Nolan Townsend | Chief Executive Officer | 24 de septiembre de 2026 A | 376 778 | 0 | 8 | $-655 514 |
| Louis Edward Tamayo | Chief Financial Officer | 24 de septiembre de 2026 A | 92 907 | 0 | 2 | $-41 052 |
| Kyle Rasbach | Chief Financial Officer | 17 de enero de 2025 A | 40 875 | 0 | 0 | $0 |
| Jose Manuel Otero | Chief Operating Officer | 24 de septiembre de 2026 A | 138 288 | 0 | 8 | $-85 566 |
| Narinder Pal Bhalla | Chief Medical Officer | 24 de septiembre de 2026 A | 84 908 | 0 | 1 | $-98 593 |
| Tai Sandi See | Chief Development Officer | 18 de noviembre de 2025 S | 65 476 | 0 | 3 | $-38 364 |
| Jenny Robertson | Chief Legal Officer | 18 de noviembre de 2025 S | 68 381 | 0 | 3 | $-36 636 |
| Eric Adler | Chief Medical Officer | 18 de noviembre de 2025 S | 72 646 | 0 | 3 | $-35 959 |
| Paul Mccormac | Chief Technical Officer | 7 de noviembre de 2023 C | 17 349 | 0 | 0 | $0 |
| Brenda Cooperstone | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Tolga Tanguler | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Timothy Van Hauwermeiren | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Mette Kirstine Agger | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Steven Altschuler | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Reinaldo M Diaz | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| CHOLMONDELEY PAULA H | Consejero | 25 de junio de 2026 A | 30 627 | 0 | 0 | $0 |
| Laura Sepp-Lorenzino | Consejero | 28 de abril de 2026 A | · | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | Propietario del 10% | 7 de noviembre de 2023 C | 1 835 959 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 24 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,63% | 71 124 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,07% | 239 703 SH | 11 de septiembre de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,07% | 82 556 NS | 31 de julio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 139 450 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 61 750 SH | 19 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,02% | 463 718 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,02% | 1 128 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 5 711 SH | 1 de octubre de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 812 282 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 407 613 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 33 862 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 62 956 SH | 1 de octubre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 254 051 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 171 599 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 683 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 5 030 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 91 142 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 19 515 SH | 10 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 10 699 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10 265 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 715 087 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 335 144 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 013 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 661 270 SH | 11 de septiembre de 2026 | Diario |
LXEO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 16 analistas
COMPRA
Objetivo mediano
$20.00
+466,6%
8 50,0%
Compra fuerte
7 43,8%
Compra
1 6,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
10 analistas · 2026-09-29Objetivo medio $20.30 +475,1%
← Por Debajo de Todos los Objetivos
Precio Actual $3.53
Mín$9.00
Media$20.30
Máx$30.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| SCTX | · | · | · | · | · | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
| RCKT | · | · | · | · | · | · |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026